The University of Southampton
University of Southampton Institutional Repository

Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease
Omega-3 (n?3) polyunsaturated fatty acids (n?3 PUFAs) have well documented anti-inflammatory properties, and consequently therapeutic potential in chronic inflammatory diseases. Here we discuss the effects of n?3 PUFAs on various inflammatory pathways and how this leads to alterations in the function of inflammatory cells, most importantly endothelial cells and leukocytes. Strong evidence indicates n?3 PUFAs are beneficial as a dietary supplement in certain diseases such as rheumatoid arthritis; however for other conditions such as asthma, the data are less robust. A clearer understanding of the pharmacology of n?3 PUFAs will help to establish targets to modulate chronic inflammatory diseases.
omega-3 polyunsaturated fatty acid, eicosapentaenoic acid, docosahexaenoic acid, inflammation, eicosanoid, resolvin
0163-7258
272-282
Yates, C.M.
d1bf844a-a526-4dff-9528-52666d4e8278
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Rainger, G.E.
0bbadb52-915e-4217-aa9b-e1974eda8031
Yates, C.M.
d1bf844a-a526-4dff-9528-52666d4e8278
Calder, P.C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Rainger, G.E.
0bbadb52-915e-4217-aa9b-e1974eda8031

Yates, C.M., Calder, P.C. and Rainger, G.E. (2014) Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease. Pharmacology & Therapeutics, 141 (3), 272-282. (doi:10.1016/j.pharmthera.2013.10.010). (PMID:24201219)

Record type: Review

Abstract

Omega-3 (n?3) polyunsaturated fatty acids (n?3 PUFAs) have well documented anti-inflammatory properties, and consequently therapeutic potential in chronic inflammatory diseases. Here we discuss the effects of n?3 PUFAs on various inflammatory pathways and how this leads to alterations in the function of inflammatory cells, most importantly endothelial cells and leukocytes. Strong evidence indicates n?3 PUFAs are beneficial as a dietary supplement in certain diseases such as rheumatoid arthritis; however for other conditions such as asthma, the data are less robust. A clearer understanding of the pharmacology of n?3 PUFAs will help to establish targets to modulate chronic inflammatory diseases.

This record has no associated files available for download.

More information

Published date: March 2014
Keywords: omega-3 polyunsaturated fatty acid, eicosapentaenoic acid, docosahexaenoic acid, inflammation, eicosanoid, resolvin
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 361817
URI: http://eprints.soton.ac.uk/id/eprint/361817
ISSN: 0163-7258
PURE UUID: f24a7136-f9b3-4f67-8ceb-fbc2e1480f86
ORCID for P.C. Calder: ORCID iD orcid.org/0000-0002-6038-710X

Catalogue record

Date deposited: 04 Feb 2014 14:36
Last modified: 15 Mar 2024 02:50

Export record

Altmetrics

Contributors

Author: C.M. Yates
Author: P.C. Calder ORCID iD
Author: G.E. Rainger

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×